Liz Hockley

Articles by Liz Hockley

Americas

MSN scores win in battle with Novartis over heart drug generic

Columbia court backs FDA approval of Entresto generic I Novartis appealing August ruling in Delaware that denied injunction.   22 October 2024

Americas

GSK fires pair of COVID and RSV lawsuits at Moderna

UK biopharma company says US rival infringed patented mRNA technology I Moderna ‘touted speed’ of Spikevax development but used protected inventions, according to suit | Moderna reported over $6bn globally in 2023 from the Spikevax products.   16 October 2024

Europe

Jones Day hires pharma and high-tech patent litigator for London office

Global law firm recruits former CMS partner to IP practice I Patent lawyer brings expertise in pharmaceuticals, tech and AI   15 October 2024

Americas

Regeneron denied safe harbour defence in COVID-19 drug dispute

Judge says use of patented protein mNeonGreen not covered by Section 271(e)(1) provision I Allele granted summary judgment in patent infringement suit.   8 October 2024

Americas

Boehringer sues Indian manufacturer over diabetes drug generic

German pharma giant claims Granules India’s ANDA infringes five patents I Combination therapy Jentadueto among Boehringer’s top three products in 2023   3 October 2024

Europe

UK judge ends J&J unit’s hopes of reviving Stelara patent

Janssen Biotech denied permission to appeal invalidation of ustekinumab patent I Samsung Bioepis convinced UK court to revoke patent in July.   1 October 2024

Europe

Drug approvals up but global innovation declines

WIPO’s Global Innovation Index reveals most innovative nations | Higher-value inventions attracting investors in a more difficult climate | Switzerland retains most innovative economy spot with India’s ‘exciting’ growth a highlight.   26 September 2024

Americas

Court denies Regeneron bid to halt copy of blockbuster eye drug

Biotech’s motion for preliminary injunction to prevent Eylea biosimilar rejected I Regeneron has filed multiple suits over rivals’ copies of aflibercept.   24 September 2024

Americas

Gilead scores win in fake HIV drug dispute

New York court grants Gilead’s contempt motion | Defendant violated asset freeze order by selling and mortgaging properties   19 September 2024

Americas

Sandoz wins $137.2m payout for lost profits in generic launch

Court finds United Therapeutics breached settlement agreement by restricting distribution of cartridges | Sandoz alleged rival hampered launch of generic medication for pulmonary arterial hypertension   17 September 2024

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.